CVS Health Reports Fourth Quarter and Full Year Results and Provides 2019 Full Year Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
CVS Health (CVS) PT Lowered to $68 at Baird
February 21, 2019 8:35 AM ESTBaird analyst Eric Coldwell lowered the price target on CVS Health (NYSE: CVS) to $68.00 (from $86.00) while maintaining a Neutral rating. Mid-$7 EPS in 2020 looks like a best-case scenario. Derivative reads scattered throughout CVS update, most of them unfavorable for peers/vendors.
CVS is... More
CVS Health (CVS) Tops Q4 EPS by 9c, FY EPS Guidance Misses
February 20, 2019 6:56 AM ESTCVS Health (NYSE: CVS) reported Q4 EPS of $2.14, $0.09 better than the analyst estimate of $2.05. Revenue for the quarter came in at $54.4 billion versus the consensus estimate of $54.58 billion.
GUIDANCE:
CVS Health sees FY2019 EPS of $6.68-$6.88, versus the consensus of... More
